Valuation: West Pharmaceutical Services, Inc.

Market Cap 24.73B 128B 21.42B 20.07B 18.31B 34.42B 2,359B 34.95B 236B 92.29B 1,181B 92.84B 90.83B 3,938B P/E 2026 *
41x
P/E 2027 * 35.6x
Enterprise Value 24.22B 125B 20.99B 19.66B 17.94B 33.72B 2,311B 34.24B 231B 90.41B 1,157B 90.95B 88.98B 3,858B EV / Sales 2026 *
7.18x
EV / Sales 2027 * 6.6x
Free-Float
92.89%
Yield 2026 *
0.26%
Yield 2027 * 0.28%
1 day+0.16%
1 week+0.16%
Current month+0.16%
1 month-2.41%
3 months+13.69%
6 months+48.78%
Current year+25.93%
1 month 51.23
Extreme 51.23
53.25
Current year 34.5
Extreme 34.5
53.25
1 year 34.5
Extreme 34.5
53.25
3 years 32.64
Extreme 32.64
60
5 years 30.7
Extreme 30.7
75.51
10 years 30.7
Extreme 30.7
75.51
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-23
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+0.16% - - 24.73B
+1.08%+5.17%-15.57%+5.32% 190B
+0.09%+5.29%-2.14%+8.76% 116B
-5.90%+2.58%+8.07%+67.67% 63.71B
-0.91%+0.33%+34.28%+58.74% 55.13B
+1.20%+7.91%-4.63%-34.97% 49.41B
+1.42%+4.44%+16.63%-18.70% 33.79B
+1.31%-15.56% - - 30.74B
+0.26%+1.01%+46.59%-10.75% 24.73B
+0.89%+11.86%-5.01%+19.22% 23.85B
Average -0.04%+3.03%+9.78%+11.91% 65.26B
Weighted average by Cap. -0.05%+4.03%+1.02%+13.31%

Financials

2026 *2027 *
Net sales 3.37B 17.44B 2.92B 2.74B 2.5B 4.7B 322B 4.77B 32.22B 12.59B 161B 12.67B 12.39B 537B 3.59B 18.54B 3.11B 2.91B 2.66B 4.99B 342B 5.07B 34.25B 13.39B 171B 13.47B 13.18B 571B
Net income 615M 3.18B 532M 499M 455M 855M 58.61B 869M 5.87B 2.29B 29.35B 2.31B 2.26B 97.86B 701M 3.62B 608M 569M 519M 976M 66.88B 991M 6.69B 2.62B 33.49B 2.63B 2.58B 112B
Net Debt -503M -2.6B -436M -409M -373M -701M -48B -711M -4.81B -1.88B -24.03B -1.89B -1.85B -80.14B -1.04B -5.37B -900M -844M -769M -1.45B -99.11B -1.47B -9.92B -3.88B -49.63B -3.9B -3.82B -165B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
352.29USD
Average target price
404.73USD
Spread / Average Target
+14.89%

Quarterly revenue - Rate of surprise